$102.08
-1.52 (-1.47%)
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
CAPS Rating:
The Company is a biopharmaceutical company that discovers, develops, and intends to commercialize pharmaceutical products for the treatment of serious medical conditions.
RSS Headlines
Fool UK